Elsevier

Annals of Emergency Medicine

Volume 21, Issue 9, September 1992, Pages 1125-1130
Annals of Emergency Medicine

Brief report
Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model

https://doi.org/10.1016/S0196-0644(05)80657-2Get rights and content

Study objectives:

Epinephrine improves coronary perfusion pressure during CPR. However, administration of epinephrine during CPR may be delayed or omitted if IV or endotracheal access is not established. Therefore, the objective of this study was to determine if intranasal administration of epinephrine during CPR would provide an alternate route of drug administration that is readily accessible and requires no special technical skills.

Design and setting:

Randomized blinded study performed in a controlled laboratory environment.

Type of participants:

Twenty mongrel dogs weighing 19.5 ± 4.6 kg.

Interventions:

All dogs received either IV epinephrine 0.015 mg/kg or intranasal epinephrine 14mg per nostril. Phentolamine (5mg per nostril) was administered intranasally one minute before nasal administration of epinephrine to improve absorption. Each dog underwent three minutes of ventricular fibrillation followed by seven minutes of CPR with a pneumatic chest compression device. Epinephrine was administered at two minutes into CPR.

Measurements and main results:

Seven dogs were excluded because of inadequate baseline coronary perfusion pressure or compression device displacement, leaving a total of 13 dogs for analysis (six IV epinephrine, seven intranasal epinephrine). Baseline coronary perfusion pressure (mean ± SD) was similar for IV epinephrine and intranasal epinephrine (16.9 ± 7.1 mm Hg versus 18.2 ± 13.8mm Hg, respectively, P = .84). For IV and intranasal epinephrine, coronary perfusion pressure increased to 21.4 ± 9.2 mm Hg and 24.4 ± 18.7 mm Hg one minute after epinephrine, respectively (P = .73). Five minutes after epinephrine coronary perfusion pressure was 18.2 ± 8.7 mm Hg and 24.3 ± 13.9 mm Hg for IV epinephrine and intranasal epinephrine, respectively (P = .38). The rate of successful resuscitation was similar for both groups, five of seven dogs for intranasal epinephrine and four of six dogs for IV epinephrine (P = .66).

Conclusion:

Intranasal epinephrine has similar effects on coronary perfusion pressure and resuscitation compared with standard-dose IV epinephrine. Therefore, the nasal route for administration of epinephrine appears to be an acceptable alternate method of drug delivery during CPR and compares favorably with standard IV therapy in the canine model. Because of the obvious benefits to human patients, these observations suggest further investigation.

References (10)

There are more references available in the full text version of this article.

Cited by (30)

  • Effects of nasal drug delivery device and its orientation on sprayed particle deposition in a realistic human nasal cavity

    2016, Computers in Biology and Medicine
    Citation Excerpt :

    The nasal route for therapeutic agent delivery is an attractive proposition due to the possibility of obtaining a systemic and local response, especially when rapid absorption and effect are desired [5,33]. Nasal sprays are seen as a more efficient way compared with injection or pills to transport drugs with potential use in bypassing the blood-brain barrier [2]. Due to the filtration effect of anterior nostril, majority of sprayed droplets deposits in the anterior nasal cavity [1,14,21,31].

  • Clinical evaluation of intranasal benzodiazepines, α<inf>2</inf>- agonists and their antagonists in canaries

    2006, Veterinary Anaesthesia and Analgesia
    Citation Excerpt :

    The nasal mucosa represents a highly permeable route of drug absorption, and a number of drugs are absorbed systemically at this site. Intranasal administration of epinephrine during cardiac arrest and cardiopulmonary resuscitation has been attempted in dogs (Bleske et al. 1992) while IN sedatives and analgesics have been used in human paediatric patients (Wilton et al. 1988; Rey et al. 1991; Karl et al. 1992; Kendall et al. 2001). The attainment of significant plasma midazolam concentrations occurs as early as 10 minutes after IN administration in human beings (Walbergh et al. 1991).

  • Drugs in modern resuscitation

    1997, British Journal of Anaesthesia
View all citing articles on Scopus

Presented at the American College of Clinical Pharmacy Annual Meeting in Minneapolis, Minnesota, August 1991.

View full text